The Stem Cell Podcast

Ep. 72: “Modeling ALS with Stem Cells” Featuring Dr. Ritchie Ho

Aug 16, 2016
Joining the discussion is Dr. Ritchie Ho, a postdoctoral scientist at Cedars-Sinai specializing in regenerative medicine and ALS research. He shares insights on modeling ALS using iPSC-derived motor neurons and how these models can reflect both familial and sporadic cases of the disease. Ritchie emphasizes the importance of assessing the maturity of these neurons and integrating clinical data to enhance ALS studies. He also highlights the impact of public initiatives like the Ice Bucket Challenge on research funding and collaboration in the field.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

NIH Plans Case-By-Case Chimera Review

  • NIH proposed replacing the chimera moratorium with an internal review for sensitive experiments while keeping breeding bans for human-cell chimeras.
  • The policy aims to allow scientific value while addressing ethical worries about human contribution to brain or germline.
ANECDOTE

From Reprogramming To Disease Modeling

  • Ritchie Ho moved from studying reprogramming mechanisms at UCLA to disease modeling at Cedars-Sinai because he wanted to apply iPSC tools to human disease.
  • He joined Clive Svensson's institute to work on patient-derived models like ALS motor neurons.
INSIGHT

Familial Cases Anchor Sporadic ALS Models

  • Modeling both familial and sporadic ALS with patient iPSCs helps reveal convergent disease pathways.
  • Familial mutations provide pathway anchors to see whether sporadic cases share the same cellular defects.
Get the Snipd Podcast app to discover more snips from this episode
Get the app